|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 2101 L Street, NW |
Address2 | Suite 1000 |
| City | Washington |
State | DC |
Zip Code | 20037 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 16896-1006486
|
||||||||
|
6. House ID# 315950507
|
||||||||
| TYPE OF REPORT | 8. Year | 2016 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: CHRISTINE SCHAUT |
Date | 1/24/2017 12:18:31 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Monitor legislative and administrative action related to response to the Zika virus and outreach regarding same.
H.R. 2028, Further Continuing and Security Assistance Appropriations Act, 2017 (PL 114-254).
H.R. 2029, Consolidated Appropriations Act, 2016 PL (114-113).
H.R. 2577, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017.
H.R. 3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (PL 114-195).
H.R. 3299, Strengthening Public Health Emergency Response Act of 2015.
H.R. 5044, Making supplemental appropriations for fiscal year 2016 to respond to Zika virus.
H.R. 5243, Zika Response Appropriations Act, 2016
H.R. 5325, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act (PL 114-223).
S. 1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (PL 114-195).
S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act.
S.2609 - An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes.
S. 2843, A bill to provide emergency supplemental appropriations to address the Zika crisis.
S. 2899, Zika Response and Regulatory Relief Act.
S. 3117, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017
Monitor Administrative Action on Experimental Use Permits for Walbachia Pipientis wAlB strain (EPA- HQ -2015 - 0374).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Environmental Protection Agency (EPA), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rob |
Mangas |
|
|
|
Tim |
Hutchinson |
|
|
|
Graham "Rusty" |
Mathews |
|
|
|
Robert |
Charrow |
|
|
|
Joe |
Reeder |
|
|
|
Juliana |
Laurello |
|
|
|
Albert |
Wynn |
|
|
|
Hayden |
Dempsey |
|
|
|
Diane |
Blagman |
|
Chief of Staff, Rep. Bob Carr; Associate Staff, House Appropriations Committee |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Oxitec Ltd.
71 Innovation Dr.
Milton Park
Abingdon, UK
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |